Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Incidence and Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Treated within the EORTC/GIMEMA AML-12/06991 AML Trial.

Blood (2009) 114 (22): 2609.

https://doi.org/10.1182/blood.V114.22.2609.2609

Published: 2009

Journal Articles

Evaluation of Prospective Detection of PML-RARA and RARA-PML Fusion Transcripts by Real-Time Quantitative PCR (RQ-PCR) To Direct Pre-Emptive Therapy with Arsenic Trioxide (ATO) in Acute Promyelocytic Leukemia (APL) Patients Treated in the UK MRC AML15 Trial.

David J. Grimwade, J. Jovanovic, R. Hills, E. Nugent, Y. Patel, R. Flora, D. Diverio, K. Jones, H. Aslett, E. Sellwood, E. Solomon, F. Lo Coco, K. Wheatley, A. Burnett

Blood (2007) 110 (11): 541.

https://doi.org/10.1182/blood.V110.11.541.541

Published: 2007

Journal Articles

Real-Time Detection of PML-RARA and RARA-PML Fusion Transcripts in High Risk Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO): Implications for Realization of Pre-Emptive Therapy for Molecular Relapse.

David Grimwade, J.V. Jovanovic, D. Diverio, E. Nugent, A.Y. Ho, G.J. Mufti, R.K. Hills, E. Solomon, R.E. Clark, F. Lo Coco, A.K. Burnett

Blood (2006) 108 (11): 493.

https://doi.org/10.1182/blood.V108.11.493.493

Published: 2006

Journal Articles

Therapy-Related Myelodysplastic Syndrome (sMDS) /Acute Myelogenous Leukemia (sAML) in Acute Promyelocytic Leukemia (APL) Patients with Long-Lasting Molecular Remission: The GIMEMA Experience.

R. Latagliata, MD, M. Breccia, MD, P. Fazi, MD, S. Gubbiotti, MD, E. Di Bona, MD, G. Specchia, PhD, A. Chiarenza, MD, R. Murru, MD, A.M. Carella, PhD, F. Ferrara, PhD, G. Rossi, MD, L. Melillo, MD, S. Sica, MD, R. Invernizzi, MD, G. Cimino, PhD, M.C. Petti, PhD, G. Avvisati, PhD, F. Lo-Coco, PhD, F. Mandelli, PhD

Blood (2005) 106 (11): 884.

https://doi.org/10.1182/blood.V106.11.884.884

Published: 2005

Journal Articles

Long-Term Results of the GIMEMA LAP AIDA 0493 Amended Protocol in Elderly Patients with Acute Promyelocytic Leukemia (APL).

Blood (2005) 106 (11): 885.

https://doi.org/10.1182/blood.V106.11.885.885

Published: 2005

Journal Articles

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

C. Nervi, MD, F. Lo Coco, MD, S. Minucci, MD, A. Careddu tech., R. Fiorini, MD, E. Finolezzi, MD, N. Noguera, PHD, L. Travaglini, PHD, V. Gelmetti, PHD, D. Diverio, PHD, S. Fenu, MD, M. Mancini, MD, C. Tatarelli, MD, M.A. Aloe Spiriti, MD, M.C. Petti, MD, G. Cimino, MD, F. Mandelli, MD, S. Amadori, MD, P.G. Pelicci, MD

Blood (2004) 104 (11): 1805.

https://doi.org/10.1182/blood.V104.11.1805.1805

Published: 2004

Journal Articles

AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study

G Avvisati, F Lo Coco, D Diverio, M Falda, F Ferrara, M Lazzarino, D Russo, MC Petti, F Mandelli

Blood (1996) 88 (4): 1390–1398.

https://doi.org/10.1182/blood.V88.4.1390.bloodjournal8841390

Published: 1996

Journal Articles

Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase

L Benedetti, F Grignani, BM Scicchitano, AM Jetten, D Diverio, F Lo Coco, G Avvisati, C Gambacorti-Passerini, S Adamo, AA Levin, PG Pelicci, C Nervi

Blood (1996) 87 (5): 1939–1950.

https://doi.org/10.1182/blood.V87.5.1939.1939

Published: 1996

Journal Articles

Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease

B Falini, B Bigerna, L Pasqualucci, M Fizzotti, MF Martelli, S Pileri, A Pinto, A Carbone, S Venturi, R Pacini, G Cattoretti, E Pescarmona, F Lo Coco, PG Pelicci, I Anagnastopoulos, R Dalla-Favera, L Flenghi

Blood (1996) 87 (2): 465–471.

https://doi.org/10.1182/blood.V87.2.465.bloodjournal872465

Published: 1996

Journal Articles

On the differentiative mode of action of All-trans retinoic acid in acute promyelocytic leukemia [letter; comment]

F Lo Coco, D Diverio, G Avvisati, F Mandelli, A Biondi, PG Pelicci

Blood (1995) 86 (8): 3264–3265.

https://doi.org/10.1182/blood.V86.8.3264.3264

Published: 1995

Journal Articles

Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features

M Fizzotti, G Cimino, S Pisegna, G Alimena, C Quartarone, F Mandelli, PG Pelicci, F Lo Coco

Blood (1995) 85 (10): 2685–2690.

https://doi.org/10.1182/blood.V85.10.2685.bloodjournal85102685

Published: 1995

Journal Articles

Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome- associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype

G Gaidano, F Lo Coco, BH Ye, D Shibata, AM Levine, DM Knowles, R Dalla-Favera

Blood (1994) 84 (2): 397–402.

https://doi.org/10.1182/blood.V84.2.397.397

Published: 1994

Journal Articles

Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma

F Lo Coco, BH Ye, F Lista, P Corradini, K Offit, DM Knowles, RS Chaganti, R Dalla-Favera

Blood (1994) 83 (7): 1757–1759.

https://doi.org/10.1182/blood.V83.7.1757.1757

Published: 1994

Journal Articles

Acute promyelocytic leukemia: from genetics to treatment

F Grignani, M Fagioli, M Alcalay, L Longo, PP Pandolfi, E Donti, A Biondi, F Lo Coco, F Grignani, PG Pelicci

Blood (1994) 83 (1): 10–25.

https://doi.org/10.1182/blood.V83.1.10.10

Published: 1994

Journal Articles

Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long- term remission

D Diverio, PP Pandolfi, A Biondi, G Avvisati, MC Petti, F Mandelli, G Pelicci, F Lo Coco

Blood (1993) 82 (12): 3556–3559.

https://doi.org/10.1182/blood.V82.12.3556.3556

Published: 1993

Journal Articles

p53 mutations are associated with histologic transformation of follicular lymphoma

F Lo Coco, G Gaidano, DC Louie, K Offit, RS Chaganti, R Dalla-Favera

Blood (1993) 82 (8): 2289–2295.

https://doi.org/10.1182/blood.V82.8.2289.2289

Published: 1993

Journal Articles

ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy

G Cimino, F Lo Coco, A Biondi, L Elia, A Luciano, CM Croce, G Masera, F Mandelli, E Canaani

Blood (1993) 82 (2): 544–546.

https://doi.org/10.1182/blood.V82.2.544.544

Published: 1993

Journal Articles

Polyclonal hematopoietic reconstitution in leukemia patients at remission after suppression of specific gene rearrangements [see comments]

F Lo Coco, PG Pelicci, F D'Adamo, D Diverio, G Alimena, E Montefusco, W Arcese, G Avvisati, L De Felice, G Meloni

Blood (1993) 82 (2): 606–612.

https://doi.org/10.1182/blood.V82.2.606.606

Published: 1993

Journal Articles

Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction

A Biondi, A Rambaldi, PP Pandolfi, V Rossi, G Giudici, M Alcalay, F Lo Coco, D Diverio, EM Pogliani, EM Lanzi

Blood (1992) 80 (2): 492–497.

https://doi.org/10.1182/blood.V80.2.492.492

Published: 1992

Journal Articles

Identification of DNA rearrangements at the retinoic acid receptor- alpha (RAR-alpha) locus in all patients with acute promyelocytic leukemia (APL) and mapping of APL breakpoints within the RAR-alpha second intron. Italian Cooperative Study Group "GIMEMA"

D Diverio, F Lo Coco, F D'Adamo, A Biondi, M Fagioli, F Grignani, A Rambaldi, V Rossi, G Avvisati, MC Petti

Blood (1992) 79 (12): 3331–3336.

https://doi.org/10.1182/blood.V79.12.3331.3331

Published: 1992

NARROW

Incidence and Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Treated within the EORTC/GIMEMA AML-12/06991 AML Trial.

Evaluation of Prospective Detection of PML-RARA and RARA-PML Fusion Transcripts by Real-Time Quantitative PCR (RQ-PCR) To Direct Pre-Emptive Therapy with Arsenic Trioxide (ATO) in Acute Promyelocytic Leukemia (APL) Patients Treated in the UK MRC AML15 Trial.

Real-Time Detection of PML-RARA and RARA-PML Fusion Transcripts in High Risk Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO): Implications for Realization of Pre-Emptive Therapy for Molecular Relapse.

Therapy-Related Myelodysplastic Syndrome (sMDS) /Acute Myelogenous Leukemia (sAML) in Acute Promyelocytic Leukemia (APL) Patients with Long-Lasting Molecular Remission: The GIMEMA Experience.

Long-Term Results of the GIMEMA LAP AIDA 0493 Amended Protocol in Elderly Patients with Acute Promyelocytic Leukemia (APL).

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study

Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase

Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease

On the differentiative mode of action of All-trans retinoic acid in acute promyelocytic leukemia [letter; comment]

Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features

Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome- associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype

Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma

Acute promyelocytic leukemia: from genetics to treatment

Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long- term remission

p53 mutations are associated with histologic transformation of follicular lymphoma

ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy

Polyclonal hematopoietic reconstitution in leukemia patients at remission after suppression of specific gene rearrangements [see comments]

Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction

Identification of DNA rearrangements at the retinoic acid receptor- alpha (RAR-alpha) locus in all patients with acute promyelocytic leukemia (APL) and mapping of APL breakpoints within the RAR-alpha second intron. Italian Cooperative Study Group "GIMEMA"

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only